Published in Diabetes Care in May 2025, the ADA’s latest report offers updated recommendations for clinicians managing patients with diabetes, focusing on type 2 diabetes (T2D), type 1 diabetes with obesity, and prediabetes. The guidelines cover changes in terminology, epidemiology, fibrosis risk stratification, monitoring, treatment, and referral guidance, emphasizing interprofessional team management. This update provides crucial insights for healthcare professionals navigating the complexities of diabetes care, highlighting the importance of tailored treatment strategies and collaborative approaches to improve patient outcomes.
The new MASLD guidelines not only address the latest advancements in diabetes management but also underscore the significance of personalized care and multidisciplinary teamwork in optimizing patient health. By incorporating the rationale behind terminology changes, fibrosis risk assessment, and comprehensive monitoring strategies, clinicians can enhance their approach to diabetes treatment. This comprehensive update serves as a valuable resource for healthcare providers seeking to stay abreast of evolving practices in diabetes care and underscores the ADA’s commitment to promoting evidence-based guidelines for improved patient outcomes.
Read more from medscape.com
